Senhor Pharmaceuticals Private Limited
About Senhor Pharmaceuticals Private Limited
Data last updated:
Senhor Pharmaceuticals Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 05 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U74999MP2018PTC044986. Its GSTIN is 23AAZCS8007K1ZR (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Subiraj Bhaskaran and Ranganathan Keshvan Asari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. – 04 17 Ghora Pachar Dam Road Durgesh Nagar Kokta No. – 04, Bhopal, Madhya Pradesh, India – 462021.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.57 Lakh, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹618 (net margin 0.4%) and EBITDA of ₹883 (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No. – 04 17 Ghora Pachar Dam Road Durgesh Nagar Kokta No. – 04, Bhopal, Madhya Pradesh, India – 462021
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Senhor Pharmaceuticals Private Limited
The main business activity of Senhor Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Senhor Pharmaceuticals Private Limited FY 2025 filings available
Senhor Pharmaceuticals Private Limited reported revenue of ₹1.57 Lakh (up 12% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Senhor Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 25% over three years, including 12% growth in the latest year. EBITDA rose 173% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Senhor Pharmaceuticals Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹883 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹618 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Senhor Pharmaceuticals Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Senhor Pharmaceuticals are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Senhor Pharmaceuticals Private Limited
Senhor Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Subiraj Bhaskaran | Director | 05 Feb 2018 | 8 Years 8 Months | Current |
| Ranganathan Keshvan Asari | Director | 05 Feb 2018 | 8 Years 8 Months | Current |
Peer Comparison of Senhor Pharmaceuticals Private Limited
Senhor Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medleods Pharmaceuticals Private Limited | ₹1.6 Lakh (FY 2024) | •••• | •••• | -4.0% | •••• | Maharashtra, India |
| Paramba Pharmaceuticals Private Limited | ₹1.58 Lakh (FY 2024) | •••• | •••• | -8.0% | •••• | Bhardwaj Nagar, Mohan Eghu, Bihar, India |
| Epazote Pharmaceuticals Private Limited | ₹1.58 Lakh (FY 2022) | •••• | •••• | •••• | Ambala, Haryana, India | |
| Bekim Pharmaceuticals Private Limited | ₹1.57 Lakh (FY 2016) | •••• | •••• | -52.0% | •••• | Kudason Gandhinagar, Gujarat, India |
| Medgalaxy Drugs & Pharmaceuticals Private Limited | ₹1.57 Lakh (FY 2025) | •••• | •••• | -22.0% | •••• | Mau, Uttar Pradesh, India |
| Senhor Pharmaceuticals Private Limited this company | ₹1.57 Lakh (FY 2023) | •••• | •••• | 12.0% | •••• | Bhopal, Madhya Pradesh, India |
| Ramakims Pharmaceuticals Private Limited | ₹1.56 Lakh (FY 2025) | •••• | •••• | -67.0% | •••• | Post-Sirni Bazar, Areraj, Bihar, India |
| Cogniprey Pharmaceuticals Private Limited | ₹1.56 Lakh (FY 2024) | •••• | •••• | •••• | Virar, Maharashtra, India | |
| Vengbo Pharmaceuticals Private Limited | ₹1.56 Lakh (FY 2023) | •••• | •••• | •••• | Kanpur, Uttar Pradesh, India | |
| Hygieia Pharmaceuticals Private Limited | ₹1.55 Lakh (FY 2025) | •••• | •••• | •••• | Ghatkesar, Telangana, India | |
| Sangpa Pharmaceuticals Private Limited | ₹1.54 Lakh (FY 2025) | •••• | •••• | •••• | Vasai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Senhor Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Senhor Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Senhor Pharmaceuticals Private Limited
Senhor Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Senhor Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Senhor Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Senhor Pharmaceuticals Private Limited
Senhor Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Ranganathan Keshvan Asari was appointed as Director on 05 Feb 2018.
Credit Ratings, Litigation & Regulatory Alerts for Senhor Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Senhor Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Senhor Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Senhor Pharmaceuticals Private Limited
Senhor Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAZCS8007K1ZR | Madhya Pradesh | Active | 11 Oct 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Senhor Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Senhor Pharmaceuticals Private Limited
Senhor Pharmaceuticals is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in other services, within the business services industry. It was incorporated on 05 February 2018 (8+ years old) and is registered under CIN U74999MP2018PTC044986.
Senhor Pharmaceuticals reported revenue of ₹1.57 Lakh for FY 2023 (up 12% YoY).
Senhor Pharmaceuticals has 2 current directors:
- Subiraj Bhaskaran - Director
- Ranganathan Keshvan Asari - Director
Senhor Pharmaceuticals reported a net profit of ₹618 (net margin 0.4%) and EBITDA of ₹883 (EBITDA margin 0.6%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Senhor Pharmaceuticals is 25% over three years. In the latest year (FY 2023) revenue rose 12%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Senhor Pharmaceuticals is 23AAZCS8007K1ZR, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Senhor Pharmaceuticals is U74999MP2018PTC044986. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Senhor Pharmaceuticals was incorporated on 05 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Senhor Pharmaceuticals by revenue are Medleods Pharmaceuticals Private Limited, Paramba Pharmaceuticals Private Limited, Epazote Pharmaceuticals Private Limited, Bekim Pharmaceuticals Private Limited, Medgalaxy Drugs & Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Ranganathan Keshvan Asari was appointed as Director on 05 Feb 2018. Subiraj Bhaskaran was appointed as Director on 05 Feb 2018.
The registered office of Senhor Pharmaceuticals is at Shop No. – 04 17 Ghora Pachar Dam Road Durgesh Nagar Kokta No. – 04, Bhopal, Madhya Pradesh, India – 462021.